Drug Profile
Somatropin biosimilar - CinnaGen
Alternative Names: CinnatropinLatest Information Update: 02 Oct 2021
Price :
$50
*
At a glance
- Originator CinnaGen
- Class Growth hormones; Hormonal replacements; Obesity therapies; Recombinant proteins
- Mechanism of Action Human growth hormone replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Growth disorders; Short stature; Somatotropin deficiency
Most Recent Events
- 04 Aug 2017 Launched for Growth disorders (In children) in Iran (SC, 5mg/1.5ml, and 10mg/1.5ml, pre-filled pen)
- 04 Aug 2017 Launched for Growth disorders (In children) in Iran (SC, powder for solution for injection)
- 04 Aug 2017 Launched for Short stature (In children) in Iran (SC, 5mg/1.5ml, and 10mg/1.5ml, pre-filled pen)